Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)Recruiting
NCT06462235Phase 2Updated Jun 11, 2026
Sponsor: Pfizer
Gram-negative Bacterial Infection
United States, Argentina, India, Israel, Taiwan
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerActive Not Recruiting
NCT04607421Phase 3Updated Jun 11, 2026
Sponsor: Pfizer
Neoplasms
United States, Argentina, Australia, Belgium, Brazil +24 more
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)Recruiting
NCT06215118Phase 1Updated Jun 10, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Australia, Canada
Evaluating ABRYSVO Maternal Vaccine Effectiveness Among InfantsActive Not Recruiting
NCT07249320N/AUpdated Jun 10, 2026
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
United States
Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBCCompleted
NCT04937660N/AUpdated Jun 10, 2026
Sponsor: Pfizer
Metastatic Breast Cancer
Egypt, Jordan, Lebanon, Qatar, Saudi Arabia
Etrasimod as Prevention of PouchitisRecruiting
NCT07486921Phase 2Updated Jun 10, 2026
Sponsor: Maia Kayal
Pouchitis
United States
A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world SettingsCompleted
NCT07200128N/AUpdated Jun 10, 2026
Sponsor: Pfizer
Severe Alopecia Areata
United States
A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive LymphomaCompleted
NCT03505554Phase 2Updated Jun 10, 2026
Sponsor: University of Milano Bicocca
Anaplastic Large Cell Lymphoma, ALK-Positive
Italy
A Study to Learn About Sickle Cell Disease In Adult PatientsCompleted
NCT05407805N/AUpdated Jun 10, 2026
Sponsor: Pfizer
Sickle Cell Disease
United States
A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy AdultsRecruiting
NCT07594769Phase 1Updated Jun 10, 2026
Sponsor: Pfizer
Migraine
Belgium
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in AdultsCompleted
NCT06182124Phase 1, Phase 2Updated Jun 10, 2026
Sponsor: Pfizer
Pneumococcal Disease
United States
A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144Completed
NCT07636018Phase 1Updated Jun 9, 2026
Sponsor: Pfizer
Healthy Adults
Belgium
Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily HeadachesRecruiting
NCT05306899Phase 3Updated Jun 8, 2026
Sponsor: University Health Network, Toronto
Chronic Daily Headache
Canada
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase InhibitorActive Not Recruiting
NCT02738866Phase 2Updated Jun 5, 2026
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Metastatic Breast Cancer
United States
An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung CancerTerminated
NCT04189614Phase 1Updated Jun 4, 2026
Sponsor: AbbVie
Cancer · Non-small Cell Lung Cancer (NSCLC)
United States, Israel, Japan, South Korea, Spain +1 more
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple MyelomaRecruiting
NCT06974786Phase 2Updated Jun 4, 2026
Sponsor: SCRI Development Innovations, LLC
Multiple Myeloma, Newly Diagnosed · Multiple Myeloma (MM)
United States
Study of PF-07265807 in Participants With Metastatic Solid Tumors.Terminated
NCT04458259Phase 1Updated Jun 4, 2026
Sponsor: Pfizer
Neoplasm Metastasis
United States, Canada, Italy, Japan, Spain
PF-07284892 in Participants With Advanced Solid TumorsTerminated
NCT04800822Phase 1Updated Jun 4, 2026
Sponsor: Pfizer
Solid Tumor
United States
An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)Completed
NCT05477524Phase 3Updated Jun 4, 2026
Sponsor: Pfizer
Lyme Disease
United States, Canada, Finland, Germany, Netherlands +2 more
A Study for Multiple Tablet Forms of The Study Medicine (PF-07220060) in Healthy AdultsCompleted
NCT05923411Phase 1Updated Jun 4, 2026
Sponsor: Pfizer
Healthy Participants
United States
A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting ConditionsActive Not Recruiting
NCT07587697Phase 1Updated Jun 3, 2026
Sponsor: Pfizer
Healthy Adults
Japan
Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In SwedenCompleted
NCT04338204N/AUpdated Jun 3, 2026
Sponsor: Pfizer
Ulcerative Colitis
Sweden
An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.Completed
NCT07527832N/AUpdated Jun 3, 2026
Sponsor: Pfizer
Colorectal Cancer
Japan
A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.Recruiting
NCT06703606Phase 1Updated Jun 3, 2026
Sponsor: Pfizer
Severe Hemophilia A
United States, India, Turkey (Türkiye)
Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15Completed
NCT05546476Phase 2Updated Jun 3, 2026
Sponsor: Pfizer
Non-small Cell Lung Cancer · Pancreatic Cancer · Colorectal Cancer · Loss of Appetite
United States, Australia, Bulgaria, Canada, China +6 more

Previous page Next page